Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6221)
All Articles published online
|
Publishing Process of This Article
|
Jul 15, 2024 (publication date) through Dec 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Ma XL, Ge D, Hu XJ. Evaluation of teplizumab's efficacy and safety in treatment of type 1 diabetes mellitus: A systematic review and meta-analysis. World J Diabetes 2024; 15(7): 1615-1626 [PMID: 39099823 DOI: 10.4239/wjd.v15.i7.1615] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Ma XL, Ge D, Hu XJ. Evaluation of teplizumab's efficacy and safety in treatment of type 1 diabetes mellitus: A systematic review and meta-analysis. World J Diabetes 2024; 15(7): 1615-1626 [PMID: 39099823 DOI: 10.4239/wjd.v15.i7.1615] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i7/1615.htm |
| Number | Citing Articles |
| 1 |
Brody Sundheim, Krish Hirani, Mateo Blaschke, Joana R. N. Lemos, Rahul Mittal. Pre-Type 1 Diabetes in Adolescents and Teens: Screening, Nutritional Interventions, Beta-Cell Preservation, and Psychosocial Impacts. Journal of Clinical Medicine 2025; 14(2): 383 doi: 10.3390/jcm14020383
|
| 2 |
Sunetra Mondal, Joseph M Pappachan. Current perspectives and the future of disease-modifying therapies in type 1 diabetes. World Journal of Diabetes 2025; 16(1): 99496 doi: 10.4239/wjd.v16.i1.99496
Abstract(547) |
Core Tip(526) |
Full Article(HTML)(3421)
|
Full Article with Cover (PDF)-12141K(139)
|
Audio-684K(10)
|
Peer-Review Report-234K(113)
|
Answering Reviewers-48K(101)
|
Supplementary Material-74K(96)
|
Full Article (PDF)-11580K(161)
|
Full Article (XML)-162K(72)
|
Times Cited (1)
|
Total Visits (7768)
|
Open
|
| 3 |
Gabriele Sassi, Pierre Lemaitre, Laia Fernández Calvo, Francesca Lodi, Álvaro Cortés Calabuig, Samal Bissenova, Amber Wouters, Laure Degroote, Marijke Viaene, Niels van Damme, Lauren Higdon, Peter S. Linsley, S. Alice Long, Chantal Mathieu, Conny Gysemans. Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes. Journal of Clinical Investigation 2025; 135(23) doi: 10.1172/JCI176403
|
| 4 |
Qi Wu, Rui Wei, Xinyue Liao, Xiaona Cui, Haining Wang, Tianpei Hong. Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes: an updated systematic review and meta-analysis. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02696-7
|